Malaisia - inglise - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

excel herbal industries sdn. bhd. - ruta graveolens folium; rhizoma atractylodes macrocephala koidz.; radix glycyrrhizae uralensis preparata; aucklandia lappa decne; prunus mume sieb. et zucc; pinellia ternata breite rhizoma; herba agastache rugosus; chaenomeles speciosa fructus -

Malaisia - inglise - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

excel herbal industries sdn. bhd. - ruta graveolens folium; rhizoma atractylodes lancea; radix glycyrrhizae uralensis preparata; pinellia ternata breite rhizoma; herba agastache rugosa; fructus prunus mume; chaenomeles speciosa fructus -

Euroopa Liit - inglise - EMA (European Medicines Agency)

mylan s.a.s. - lopinavir/ritonavir - hiv infections - antivirals for systemic use, - lopinavir/ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv-1) infected adults, adolescents and children above the age of 2 years.the choice of lopinavir/ritonavir to treat protease inhibitor experienced hiv-1 infected patients should be based on individual viral resistance testing and treatment history of patients.

Euroopa Liit - inglise - EMA (European Medicines Agency)

mylan s.a.s. - rasagiline tartrate - parkinson disease - anti-parkinson drugs - rasagiline mylan is indicated for the treatment of idiopathic parkinson’s disease (pd) as monotherapy (without levodopa) or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.

Euroopa Liit - inglise - EMA (European Medicines Agency)

csl behring gmbh - alpha1-proteinase inhibitor (human) - genetic diseases, inborn, lung diseases - antihemorrhagics, - respreeza is indicated for maintenance treatment, to slow the progression of emphysema in adults with documented severe alpha1-proteinase inhibitor deficiency (e.g. genotypes pizz, piz(null), pi(null,null), pisz). patients are to be under optimal pharmacologic and non-pharmacologic treatment and show evidence of progressive lung disease (e.g. lower forced expiratory volume per second (fev1) predicted, impaired walking capacity or increased number of exacerbations) as evaluated by a healthcare professional experienced in the treatment of alpha1-proteinase inhibitor deficiency.,

Euroopa Liit - inglise - EMA (European Medicines Agency)

h. lundbeck a/s - nalmefene hydrochloride dihydrate - alcohol-related disorders - drugs used in alcohol dependence - selincro is indicated for the reduction of alcohol consumption in adult patients with alcohol dependence who have a high drinking-risk level (see section 5.1), without physical withdrawal symptoms and who do not require immediate detoxification.selincro should only be prescribed in conjunction with continuous psychosocial support focused on treatment adherence and reducing alcohol consumption.selincro should be initiated only in patients who continue to have a high drinking-risk level two weeks after initial assessment.

Euroopa Liit - inglise - EMA (European Medicines Agency)

bayer ag - riociguat - hypertension, pulmonary - antihypertensives for pulmonary arterial hypertension - chronic thromboembolic pulmonary hypertension (cteph) adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah) adempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. efficacy has been shown in a pah population including aetiologies of idiopathic or heritable pah or pah associated with connective tissue disease.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

promis medical australia pty ltd - 37090 - adaptor, endoscope element - a connector intended to join or bring together one or more endoscope elements thereby creating a complete endoscope assembly. it may also be fitted with stop-cocks or instrument ports for the introduction of, e.g. instruments, catheters.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

promis medical australia pty ltd - 37090 - adaptor, endoscope element - these adapters are to be used with ring applicators during laproscopic proceedures, or with trocar sleeves. they are intended to allow greater safety for trocars and applicators when making incisions for surgery by allowing different positioning of other endoscopic elements. these devices are supplied non-sterile and are reusable.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

promis medical australia pty ltd - 37096 - cable, - a device that provides a connection between two or more devices for the intended purpose of transmitting an energy that may, or may not, contain information.